Riskpilot← Back to searchSign inGet full accessDoctrix Medica AB
ABActiveOrg 5592766660Ejdervägen 17General medical practice activities · NACE 8621Est. 20200 employees
Revenue 2025
SEK 197K
+74% vs 2024
EBITDA margin
71.2%
+74% vs 2024
Equity ratio
69.4%
Financial strength
Net profit 2025
SEK 112K
+73% vs 2024
| Revenue | SEK 197K | +74% |
| EBITDA | SEK 140K | +74% |
| Net profit | SEK 112K | +73% |
| Total assets | SEK 204K | +51% |
| Equity | SEK 141K | +49% |
| Employees | 0 | — |
Legal name
Doctrix Medica AB
Org number
5592766660
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
14 oktober 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom primärvård i egenskap av läkare, på klinik samt digitalt samt därmed förenlig verksamhet. Bolaget kommer att verka inom hälso- och sjukvård, friskvård, utbildning och rådgivning inom medicin och friskvård samt därmed förenlig verksamhet. Därutöver skall bolaget bedriva handel med aktier, värdepapper och därtill associerade finansiella instrument, fordon och fastigheter inom riket eller utrikes.
Address
Ejdervägen 17
Email
ami_schultz@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 123 | 269 | 229 | 113 | 197 |
| Staff expenses | — | −118 | −15 | −5 | −32 |
| EBITDA | 105 | 124 | 190 | 81 | 140 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 105 | 124 | 190 | 81 | 140 |
| Net financials | — | — | 0 | 1 | 0 |
| Profit before tax | 105 | 124 | 190 | 81 | 141 |
| Tax | −23 | −26 | −40 | −17 | −29 |
| Net profit | 82 | 98 | 150 | 65 | 112 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 173 | 250 | 244 | 135 | 204 |
| Equity | 107 | 125 | 175 | 95 | 141 |
| Long-term debt | 11 | 2 | −1 | 0 | 0 |
| Short-term debt | 54 | 123 | 70 | 40 | 62 |
| Total debt | 65 | 125 | 70 | 40 | 62 |
EBITDA margin
71.2%
This company
15.8%
Market median
+351% vs market
20212025
Equity ratio
69.4%
This company
38.2%
Market median
+82% vs market
20212025
Return on equity
79.1%
This company
18.4%
Market median
+330% vs market
20212025
Net profit margin
56.6%
This company
8.1%
Market median
+599% vs market
20212025
Asset turnover
0.97×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Doctrix Medica AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Johan Anders Wickman | Deputy Board Member | 0 companies |
| Ann-Marie Schultz | Board of Directors | 0 companies |